138 related articles for article (PubMed ID: 14692521)
1. Current concepts of the immunobiology and immunotherapy of cutaneous T cell lymphoma: insights gained through cross-talk between the clinic and the bench.
Berger CL; Edelson RL
Leuk Lymphoma; 2003 Oct; 44(10):1697-703. PubMed ID: 14692521
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
3. Interaction of cutaneous lymphoma cells with reactive T cells and dendritic cells: implications for dendritic cell-based immunotherapy.
Thumann P; Lüftl M; Moc I; Bagot M; Bensussan A; Schuler G; Jenne L
Br J Dermatol; 2003 Dec; 149(6):1128-42. PubMed ID: 14674889
[TBL] [Abstract][Full Text] [Related]
4. Advances in understanding the immunobiology and immunotherapy of cutaneous T-cell lymphoma.
Berger CL; Mariwalla K; Girardi M; Edelson RL
Adv Dermatol; 2004; 20():217-35. PubMed ID: 15544202
[No Abstract] [Full Text] [Related]
5. T-cell technology in the diagnosis & management of cutaneous T-cell lymphoma.
Duncan KO; Heald PW
Compr Ther; 1998 Mar; 24(3):117-22. PubMed ID: 9559245
[TBL] [Abstract][Full Text] [Related]
6. Vaccine therapy for cutaneous T-cell lymphoma.
Seo N; Furukawa F; Tokura Y; Takigawa M
Hematol Oncol Clin North Am; 2003 Dec; 17(6):1467-74. PubMed ID: 14710897
[TBL] [Abstract][Full Text] [Related]
7. A new nail in the CTCL coffin.
Lessin SR
J Invest Dermatol; 2006 Nov; 126(11):2368-9. PubMed ID: 17041618
[TBL] [Abstract][Full Text] [Related]
8. The dynamic interplay of malignant and benign T cells in cutaneous T-cell lymphoma.
Herrick C; Heald P
Dermatol Clin; 1997 Jan; 15(1):149-57. PubMed ID: 9001868
[TBL] [Abstract][Full Text] [Related]
9. Innovative Treatment Concepts for Cutaneous T-Cell Lymphoma Based on Microenvironment Modulation.
Leuchte K; Schlaak M; Stadler R; Theurich S; von Bergwelt-Baildon M
Oncol Res Treat; 2017; 40(5):262-269. PubMed ID: 28423378
[TBL] [Abstract][Full Text] [Related]
10. Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.
Damsky WE; Choi J
Curr Treat Options Oncol; 2016 Jul; 17(7):33. PubMed ID: 27262707
[TBL] [Abstract][Full Text] [Related]
11. The life cycle of cutaneous T cell lymphoma reveals opportunities for targeted drug therapy.
Berger CL; Edelson R
Curr Cancer Drug Targets; 2004 Nov; 4(7):609-19. PubMed ID: 15578918
[TBL] [Abstract][Full Text] [Related]
12. [Immuno-intervention in cutaneous lymphomas].
Dummer R; Heinzerling L; Schmid MH; Burg G
Praxis (Bern 1994); 2000 Sep; 89(37):1471-6. PubMed ID: 11037619
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
Nagatani T; Miyazawa M; Matsuzaki T; Iemoto G; Kim ST; Baba N; Miyamoto H; Nakajima H
Semin Dermatol; 1994 Sep; 13(3):216-22. PubMed ID: 7986691
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous T cell lymphoma: translating immunobiology into therapeutic opportunities.
Berger CL; Heald P; Girardi M; Edelson RL
G Ital Dermatol Venereol; 2008 Feb; 143(1):43-54. PubMed ID: 18833050
[TBL] [Abstract][Full Text] [Related]
15. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
Wong HK
G Ital Dermatol Venereol; 2008 Dec; 143(6):375-83. PubMed ID: 19169210
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
17. CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer.
Assaf C; Gellrich S; Whittaker S; Robson A; Cerroni L; Massone C; Kerl H; Rose C; Chott A; Chimenti S; Hallermann C; Petrella T; Wechsler J; Bagot M; Hummel M; Bullani-Kerl K; Bekkenk MW; Kempf W; Meijer CJ; Willemze R; Sterry W
J Clin Pathol; 2007 Sep; 60(9):981-9. PubMed ID: 17018683
[TBL] [Abstract][Full Text] [Related]
18. High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma.
Schlapbach C; Ochsenbein A; Kaelin U; Hassan AS; Hunger RE; Yawalkar N
J Am Acad Dermatol; 2010 Jun; 62(6):995-1004. PubMed ID: 20466174
[TBL] [Abstract][Full Text] [Related]
19. Efficient tumor antigen loading of dendritic antigen presenting cells by transimmunization.
Girardi M; Berger C; Hanlon D; Edelson RL
Technol Cancer Res Treat; 2002 Feb; 1(1):65-9. PubMed ID: 12614179
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous T-cell lymphoma: a model for selective immunotherapy.
Edelson RL
Cancer J Sci Am; 1998; 4(2):62-71. PubMed ID: 9532405
[No Abstract] [Full Text] [Related]
[Next] [New Search]
